Lonza Group Ag Other Current Assets 2012-2023 | LZAGY

Lonza Group Ag other current assets from 2012 to 2023. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Lonza Group Ag other current assets for the quarter ending December 31, 2023 were $M, a 100% decline year-over-year.
  • Lonza Group Ag other current assets for 2022 were $0.503B, a 46.41% increase from 2021.
  • Lonza Group Ag other current assets for 2021 were $0.344B, a 20.27% decline from 2020.
  • Lonza Group Ag other current assets for 2020 were $0.431B, a 25.55% increase from 2019.
Lonza Group Ag Annual Other Current Assets
(Millions of US $)
2022 $503
2021 $344
2020 $431
2019 $343
2017 $175
2016 $178
2015 $1,631
2014 $152
2013 $192
2012 $159
2011 $212
Lonza Group Ag Quarterly Other Current Assets
(Millions of US $)
2023-12-31
2022-12-31 $503
2022-06-30 $3,385
2021-12-31 $344
2021-06-30 $4,971
2020-12-31 $2,584
2020-06-30 $2,668
2019-12-31 $372
2019-06-30 $2,509
2018-12-31 $3,125
2018-06-30 $2,543
2017-12-31 $175
2017-06-30 $1,779
2016-12-31 $270
2016-06-30 $1,723
2015-12-31 $1,631
2015-06-30 $1,699
2014-12-31 $152
2014-06-30 $1,895
2013-12-31 $192
2013-06-30 $1,776
2012-12-31 $159
2012-06-30 $1,790
2011-12-31 $212
2011-06-30 $1,337
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $45.279B $7.478B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $202.584B 25.84
Stryker (SYK) United States $144.427B 32.55
Boston Scientific (BSX) United States $130.404B 37.49
Medtronic (MDT) Ireland $113.203B 16.84
EssilorLuxottica (ESLOY) France $112.107B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
GE HealthCare Technologies (GEHC) United States $39.012B 20.24
ResMed (RMD) United States $36.507B 30.00
Terumo (TRUMY) Japan $30.649B 43.28
Koninklijke Philips (PHG) Netherlands $24.871B 19.04
Zimmer Biomet Holdings (ZBH) United States $21.791B 13.87
Insulet (PODD) United States $19.339B 77.01
Baxter (BAX) United States $17.458B 11.37
Smith & Nephew SNATS (SNN) United Kingdom $10.816B 0.00
Bio-Rad Laboratories (BIO) United States $10.245B 34.82
BellRing Brands (BRBR) United States $9.218B 38.97
Demant (WILYY) Denmark $8.351B 0.00
Lantheus Holdings (LNTH) United States $5.846B 13.58
TG Therapeutics (TGTX) United States $4.785B 0.00
Haemonetics (HAE) United States $4.590B 22.40
ICU Medical (ICUI) United States $4.354B 41.56
Prestige Consumer Healthcare (PBH) United States $4.039B 20.09
Perrigo (PRGO) Ireland $3.645B 10.73
Envista Holdings (NVST) United States $3.571B 26.60
Neogen (NEOG) United States $3.554B 41.00
Agios Pharmaceuticals (AGIO) United States $3.448B 0.00
GN Store Nord (GNNDY) Denmark $3.068B 19.67
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.891B 18.61
LeMaitre Vascular (LMAT) United States $2.372B 57.65
Warby Parker (WRBY) United States $2.084B 0.00
AtriCure (ATRC) United States $1.862B 0.00
Green Thumb Industries (GTBIF) United States $1.651B 28.90
InMode (INMD) Israel $1.638B 9.85
Maravai LifeSciences Holdings (MRVI) United States $1.458B 0.00
AdaptHealth (AHCO) United States $1.405B 10.05
BioLife Solutions (BLFS) United States $1.227B 0.00
Curaleaf Holdings (CURLF) Canada $1.079B 0.00
Phibro Animal Health (PAHC) United States $1.035B 18.25
Owens & Minor (OMI) United States $1.031B 8.05
CeriBell (CBLL) United States $0.983B 0.00
National Vision Holdings (EYE) United States $0.931B 31.10
Capricor Therapeutics (CAPR) United States $0.887B 0.00
Evolus (EOLS) United States $0.831B 0.00
VAREX IMAGING (VREX) United States $0.598B 18.04
Quanterix (QTRX) United States $0.588B 0.00
Surmodics (SRDX) United States $0.549B 0.00
Verano Holdings (VRNOF) United States $0.546B 0.00
Cresco Labs (CRLBF) United States $0.508B 0.00
Valneva SE (VALN) France $0.417B 0.00
ZimVie (ZIMV) United States $0.394B 33.19
Canopy Growth (CGC) Canada $0.379B 0.00
Cerus (CERS) United States $0.377B 0.00
Viemed Healthcare (VMD) United States $0.370B 35.22
OraSure Technologies (OSUR) United States $0.316B 21.20
Biote (BTMD) United States $0.312B 14.38
Sanara MedTech (SMTI) United States $0.306B 0.00
Zynex (ZYXI) United States $0.296B 62.00
MacroGenics (MGNX) United States $0.276B 0.00
Aurora Cannabis (ACB) Canada $0.262B 0.00
Jin Medical (ZJYL) China $0.250B 0.00
Omeros (OMER) United States $0.249B 0.00
Utah Medical Products (UTMD) United States $0.238B 16.05
High Tide (HITI) Canada $0.213B 88.33
TerrAscend (TSNDF) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.180B 216.00
Organigram Holdings (OGI) Canada $0.169B 0.00
FitLife Brands (FTLF) United States $0.155B 20.99
Rockwell Medical (RMTI) United States $0.144B 0.00
Zevia PBC (ZVIA) United States $0.140B 0.00
TriSalus Life Sciences (TLSI) United States $0.137B 0.00
Quipt Home Medical (QIPT) United States $0.117B 0.00
Veru (VERU) United States $0.106B 0.00
Fonar (FONR) United States $0.094B 9.76
Oramed Pharmaceuticals (ORMP) United States $0.094B 23.20
Cellectar Biosciences (CLRB) United States $0.086B 0.00
Ayr Wellness (AYRWF) United States $0.081B 0.00
Sanuwave Health (SNWVD) United States $0.079B 2.69
Modular Medical (MODD) United States $0.072B 0.00
InterCure (INCR) Israel $0.066B 0.00
Safety Shot (SHOT) United States $0.061B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
MariMed (MRMD) United States $0.055B 0.00
Jushi Holdings (JUSHF) United States $0.053B 0.00
Exagen (XGN) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.051B 0.00
Allurion Technologies (ALUR) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.028B 0.00
Nephros (NEPH) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
GlucoTrack (GCTK) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Agape ATP (ATPC) $0.006B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Senestech (SNES) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 13.60
SNDL (SNDL) Canada $0.000B 0.00